PSTV (Plus Therapeutics) OCF Margin %: 0.00% (As of Mar. 2026)


PSTV Plus Therapeutics Inc PSTV
30 GF Score
Price $4.26
! 2 Warning Signs
View Full Analysis

What is Plus Therapeutics OCF Margin %?

Plus Therapeutics PSTV +7.59% 30 OCF Margin % is 0.00% as of Mar. 2026. GuruFocus rates PSTV with a GF Score™ of 30/100. The stock has 2 warning signs investors should review. Among 960 Biotechnology companies, Plus Therapeutics ranks worse than 104166.56% on this metric.

OCF Margin % is calculated as Cash Flow from Operations divided by its Revenue. Plus Therapeutics's Cash Flow from Operations for the three months ended in Mar. 2026 was $-6.24 Mil. Plus Therapeutics's Revenue for the three months ended in Mar. 2026 was $0.00 Mil. Therefore, Plus Therapeutics's OCF Margin % for the quarter that ended in Mar. 2026 was 0.00%.

As of today, Plus Therapeutics's current OCF Yield % is -71.16%.

The historical rank and industry rank for Plus Therapeutics's OCF Margin % or its related term are showing as below:


During the past 13 years, the highest OCF Margin % of Plus Therapeutics was -84.40%. The lowest was -2783.50%. And the median was -282.76%.

PSTV's OCF Margin % is not ranked *
in the Biotechnology industry.
Industry Median: -68.59
* Ranked among companies with meaningful OCF Margin % only.

Plus Therapeutics OCF Margin % Related Terms

Plus Therapeutics OCF Margin % Historical Data

* Premium members only.

The historical data trend for Plus Therapeutics's OCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Plus Therapeutics OCF Margin % Chart

Plus Therapeutics Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
OCF Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Plus Therapeutics Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
OCF Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
PSTV
30GF Score
Plus Therapeutics Inc PSTV
OCF Margin % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Plus Therapeutics OCF Margin % Calculation

OCF Margin % is the ratio of Cash Flow from Operations divided by net sales or Revenue, usually presented in percent.

Plus Therapeutics's OCF Margin for the fiscal year that ended in Dec. 2025 is calculated as

OCF Margin=Cash Flow from Operations (A: Dec. 2025 )/Revenue (A: Dec. 2025 )
=-20.775/0
= %

Plus Therapeutics's OCF Margin for the quarter that ended in Mar. 2026 is calculated as

OCF Margin=Cash Flow from Operations (Q: Mar. 2026 )/Revenue (Q: Mar. 2026 )
=-6.238/0
= %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about OCF Margin % →
What does a OCF Margin % of 0.00% mean?
Plus Therapeutics (PSTV) has a OCF Margin % of 0.00% as of Mar. 2026. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Plus Therapeutics and its competitors. According to the industry distribution chart, Plus Therapeutics ranks #999999 out of 960 companies in the Biotechnology industry.
Is Plus Therapeutics' OCF Margin % too high?
Plus Therapeutics' current OCF Margin % is 0.00%. Based on the distribution chart, Plus Therapeutics ranks #999999 out of 960 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, Plus Therapeutics has a GF Score™ of 30/100, reflecting its overall financial health beyond just this single metric.
How does Plus Therapeutics' OCF Margin % compare to GRCE and NNVC?
According to the Biotechnology industry distribution chart, Plus Therapeutics ranks #999999 out of 960 companies for OCF Margin %. This places Plus Therapeutics in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Margin % for a Biotechnology company?
A good OCF Margin % depends on the Biotechnology industry context. However, OCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Margin % mean?
A high OCF Margin % can signal that a stock is expensive relative to its fundamentals. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Plus Therapeutics and its competitors. Plus Therapeutics's current OCF Margin % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Plus Therapeutics stock overvalued right now?
Plus Therapeutics (PSTV) has a current OCF Margin % of 0.00%. The current OCF Margin % is 0.00%. Plus Therapeutics' overall GF Score™ is 30/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Margin % calculated?
OCF Margin % is calculated from a company's financial statements. For Plus Therapeutics (PSTV), the current OCF Margin % is 0.00% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Plus Therapeutics Business Description

Other Exchanges XMP1:Germany
Address 6420 Levit Green Boulevard, Suite 210, Houston, TX, USA, 77021
Plus Therapeutics Inc is a clinical-stage pharmaceutical company that focuses on discovering, developing, commercializing and delivering complex treatments for patients with cancer and rare diseases. The company is working on a range of potential products, with its main programs targeting recurrent glioblastoma (GBM) and leptomeningeal metastases (LM). One of its key candidates, rhenium (186Re) obisbemeda, is specifically designed to treat central nervous system (CNS) cancers such as GBM, LM, and pediatric brain cancers (PBC).
30GF Score

Get the complete analysis for PSTV

OCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$4.26
Price